Dihydrotestosterone

Researchers observed a U-shaped relationship between circulating testosterone levels and fracture risk among a cohort of Australian men, with men with a midrange plasma testosterone concentration at lowest risk for sustaining any fracture or hip fracture during a decade of follow-up, according to findings from a community-based study published in The Journal of Clinical Endocrinology & Metabolism.

The FDA has accepted for review the new drug application for clascoterone cream 1% and has set Aug. 27, 2020, as the Prescription Drug User Fee Act action date.

Among men aged at least 70 years, type 2 diabetes appeared associated with a 35% reduction in risk for prostate cancer after consideration of standard risk factors, according to findings published in The Journal of Clinical Endocrinology & Metabolism.